295 related articles for article (PubMed ID: 8635097)
21. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
Abdel-Nabi HH; Doerr RJ
Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
[TBL] [Abstract][Full Text] [Related]
22. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
Doerr RJ; Herrera L; Abdel-Nabi H
Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer.
Pateisky N; Philipp K; Sevelda P; Skodler WD; Enzelsberger H; Hamilton G; Burchell J; Schatten C
Gynecol Obstet Invest; 1987; 24(3):211-6. PubMed ID: 3692333
[TBL] [Abstract][Full Text] [Related]
25. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year.
Low RN; Duggan B; Barone RM; Saleh F; Song SY
Radiology; 2005 Jun; 235(3):918-26. PubMed ID: 15914479
[TBL] [Abstract][Full Text] [Related]
26. Can pre-operative computed tomography predict resectability of ovarian carcinoma at primary laparotomy?
Byrom J; Widjaja E; Redman CW; Jones PW; Tebby S
BJOG; 2002 Apr; 109(4):369-75. PubMed ID: 12013156
[TBL] [Abstract][Full Text] [Related]
27. Computed tomography prior to surgery for ovarian carcinoma.
Simon A; Fields S; Schenker JG; Anteby SO
Aust N Z J Obstet Gynaecol; 1986 Aug; 26(3):199-202. PubMed ID: 3101658
[TBL] [Abstract][Full Text] [Related]
28. [Predictive value of preoperative abdominopelvic CT for optimal cytoreduction surgery in ovarian carcinoma].
Taïeb S; Bonodeau F; Leblanc é ; Vennin P; Fournier C; Besson P
Bull Cancer; 2000 Mar; 87(3):265-72. PubMed ID: 10779815
[TBL] [Abstract][Full Text] [Related]
29. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
[TBL] [Abstract][Full Text] [Related]
30. Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial.
Divgi CR; McDermott K; Griffin TW; Johnson DK; Schnobrich KE; Fallone PS; Scott AM; Hilton S; Cohen AM; Larson SM
J Nucl Med; 1993 Oct; 34(10):1656-61. PubMed ID: 8410278
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunoscintigraphy of metastatic breast carcinoma.
Taylor JL; Taylor DN; Lowry C; Keeling AA; Bradwell AR; McIntosh A; Rhodes A
Eur J Surg Oncol; 1992 Feb; 18(1):57-63. PubMed ID: 1737595
[TBL] [Abstract][Full Text] [Related]
32. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
Sodee DB; Sodee AE; Bakale G
Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of the combined serum CA 125 and TPS during chemotherapy and before second-look laparotomy in epithelial ovarian cancer.
Senapad S; Neungton S; Thirapakawong C; Suphanit I; Hangsubcharoen M; Thamintorn K
Anticancer Res; 2000; 20(2B):1297-300. PubMed ID: 10810438
[TBL] [Abstract][Full Text] [Related]
34. Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CT.
Balestreri L; Bison L; Sorio R; Morra A; Campagnutta E; Morassut S
Radiol Med; 2002; 104(5-6):426-36. PubMed ID: 12589264
[TBL] [Abstract][Full Text] [Related]
35. In-111 CYT-103 immunoscintigraphy of isolated splenic metastasis from ovarian carcinoma.
Nguyen BD; Regan F
Clin Nucl Med; 1997 Apr; 22(4):256-7. PubMed ID: 9099487
[No Abstract] [Full Text] [Related]
36. Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer.
Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Lele SB; Marchetti DL; Baker TR; Blumenson LE
Gynecol Oncol; 1998 Sep; 70(3):392-7. PubMed ID: 9790793
[TBL] [Abstract][Full Text] [Related]
37. Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe.
Bell J; Mojzisik C; Hinkle G; Derman H; Schlom J; Martin E
Obstet Gynecol; 1990 Oct; 76(4):607-11. PubMed ID: 2216188
[TBL] [Abstract][Full Text] [Related]
38. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunoscintigraphy of colorectal carcinoma using technetium-99m-labeled, totally human monoclonal antibody 88BV59H21-2.
Gulec SA; Serafini AN; Moffat FL; Vargas-Cuba RD; Sfakianakis GN; Franceschi D; Crichton VZ; Subramanian R; Klein JL; De Jager RL
Cancer Res; 1995 Dec; 55(23 Suppl):5774s-5776s. PubMed ID: 7493345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
